Form 4: Cencora CEO Exercises, Sells Shares Under 10b5-1 Plan

Cencora's President and CEO, Robert P. Mauch, exercised stock options and simultaneously sold an equal number of shares, as disclosed in a recent Form 4 filing.

Summary

• Robert P. Mauch, President & CEO of Cencora, Inc. (COR), reported transactions under a Rule 10b5-1 plan.
• Mauch exercised 3,762 non-qualified stock options at a price of $86.09 per share on February 20, 2026.
• Concurrently, Mauch sold 3,762 shares of Cencora Common Stock at $358.94 per share on February 20, 2026.
• Following these transactions, Mauch directly owns 65,393 shares of Cencora Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for executive compensation and personal financial planning, with no direct positive or negative implications for the company's operational performance or strategic direction.

Positives

• The insider realized a significant gain from exercising options at $86.09 and selling shares at $358.94, indicating a substantial increase in the company's stock value since the options were granted.
• The transaction was conducted under a Rule 10b5-1 plan, which suggests a pre-scheduled, non-discretionary sale, mitigating concerns about trading on material non-public information.

Negatives

• The sale of shares by a key executive, even under a 10b5-1 plan, reduces their direct ownership stake in the company.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are a common practice for executives to manage their equity holdings for diversification or liquidity purposes. These pre-arranged plans allow insiders to sell shares without concerns of trading on material non-public information, making this a routine disclosure for a public company executive in the pharmaceutical distribution industry.

Stakeholder Impact

• Shareholders: The transaction represents a routine insider sale under a pre-arranged plan, which typically has minimal impact on shareholder sentiment or company valuation, especially given the relatively small percentage of total shares outstanding.
• Employees: No direct impact on employees is indicated by this filing.
• Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the exercise of stock options and the subsequent sale of shares under a pre-arranged 10b5-1 plan. Such transactions are common for executive compensation and personal financial management and typically do not signal a change in the company's fundamental outlook or performance. Therefore, it does not provide a basis for a change in investment recommendation, and a 'hold' stance is maintained.

Keywords

Cencora, COR, Form 4, insider trading, stock options, Rule 10b5-1, executive compensation, Robert P. Mauch